Cargando…
Challenges in the diagnosis and management of immune-mediated necrotising myopathy (IMNM) in a patient on long-term statins
Immune-mediated necrotising myopathy (IMNM) is a severe and poorly understood complication of statin use. Prompt management with immunosuppressive treatment is often needed to control the condition, which differs from the management of the more commonly recognised statin-induced myopathy. We present...
Autores principales: | Khan, Faris, Brady, Stefen, Kuttikat, Anoop |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898342/ https://www.ncbi.nlm.nih.gov/pubmed/36260115 http://dx.doi.org/10.1007/s00296-022-05230-0 |
Ejemplares similares
-
Spontaneous Development of Immune-Mediated Necrotizing Myopathy (IMNM) After Chronic Use of Statins: A Case Report
por: Luong, Michael T, et al.
Publicado: (2023) -
Muscle MRI in immune-mediated necrotizing myopathy (IMNM): implications for clinical management and treatment strategies
por: Fionda, Laura, et al.
Publicado: (2022) -
3. Statin induced immune mediated necrotising myopathy: a case report
por: Banerjee, Siwalik, et al.
Publicado: (2019) -
Atorvastatin: Statin induced autoimmune necrotising myopathy: case report
Publicado: (2022) -
24. A case of necrotising autoimmune myopathy with recent statin use
por: Charan, Mahima, et al.
Publicado: (2018)